FOXM1 functions collaboratively with PLAU to promote gastric cancer progression

Conclusion: FOXM1+PLAU+ can serve as effective prognostic biomarkers and potential therapeutic targets for GC. Due to the additive effect of these two genes, screening for drugs or chemicals that targeting the expression patterns PLAU+FOXM1+ subgroup may exert important clinical impact on GC management.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Chao Ai, Jixin Zhang, Shenyi Lian, Jie Ma, Bal á zs Gy ő rffy, Zhenyuan Qian, Yong Han, Qin Feng Tags: Research Paper Source Type: research